CIGNA Corporation (CI)
Cigna Corp. provides medical, dental, disability, life and accident insurance and related products and services to businesses, governmental and non-governmental organizations and individuals. It operates through the following segments: Global Health Care; Global Supplemental Benefits; and Group Disability and Life. The Global Healthcare segment aggregates the Commercial and Government operating segments due to their similar economic characteristics, products and services and regulatory environment. The Global Supplemental Benefits segment includes supplemental health, life and accident insurance products offered in selected international markets and in the U.S. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident and specialty insurance products and related services. The company was founded in 1981 and is headquartered in Bloomfield, CT.
|Market Price at 20-11-2017
|Price to Earnings Ratio
|Return on Equity (ROE)
Blog posts that reference CIGNA Corporation:
Tuesday, October 03, 2017
Global Equity Markets in Review
· US equity benchmarks edge higher as small caps outperform
· German election results, weakness in euro powers European equities higher
· Asian equities witness volatility amid mixed political and economic news
Monday, September 04, 2017
Investing can be a volatile ride, the last few days have reminded us.
The last few days have also reminded us why holding international equities is often beneficial for Australian investors – the Australian dollar acts as a shock absorber on returns when volatility hits, which is exactly the opposite effect that international investors get investing in Australian stocks.
Monday, August 14, 2017
• US-North Korea tension rattles financial markets globally.
• MSCI World Index falls 1.5% highlighting the widespread fall in equities across the globe.
Monday, August 07, 2017
• Mixed set of earnings and economic reports drive US market.
• Currency movement and slew of earnings reports direct European markets.
• Asian markets tread water amid plethora of economic data.
Monday, July 03, 2017
• Political uncertainty, profit booking weighs on US markets.
• Strengthening currency drags European markets lower.
• Positive economic data powers China.
Wednesday, June 28, 2017
On 20 June 2017, Morgan Stanley Capital International (MSCI), a widely tracked provider of global indices, announced its decision to add China’s local currency shares (A-shares) to the MSCI Emerging Markets Index. MSCI will include around 222 large-cap Chinese equities in the index from June 2018, along with other international indices that cover Chinese stocks. The long-awaited decision, which came after three previous rejections by the global index provider, brought cheer to China’s stock markets. MSCI’s decision is seen as an acknowledgement of the progress made by China in opening its capital markets.
Monday, June 26, 2017
• Wall street finished almost flat amid low oil prices.
• Most European markets move lower as Brexit negotiations begin.
• Asian markets finished divergent on account of domestic cues.
Monday, May 08, 2017
• US stocks finished marginally higher as subdued week comes to an end.
• Breakthrough in Greece’s bailout and buoyant economic data powers European stocks higher.
• Commodity plunge plays spoilsport as Asian equities close lower.
Wednesday, May 06, 2015
Here at Skaffold, we’ve been harping on about the benefits of global investing for years. Today Smart Investor reveal the big trends set to dominate investment markets over the next thirty or so years.
It’s a really interesting article, and includes a few A1 insights on top global healthcare stocks from Skaffold too!
Tuesday, April 01, 2014
Given the uncertainty over earnings growth in 2014/15, you understandably don’t want to pay any more than you need to for top stocks. But there are occasions when you shouldn’t be deterred from paying close to or indeed above intrinsic value (IV) for quality companies on a strong growth trajectory.
As a value investor, sometimes you’re better off buying a quality business with plenty of growth in front of it at a (slight) premium to its intrinsic value than trying to save money on a bad stock that’s languishing.